71.90 
1.22(1.67%) Jun 19, 4:02PM EDT
| Prev Close: | 73.12 |
|---|
| Open: | 72.60 |
|---|
| Bid: | 70.36 x 200 |
|---|
| Ask: | 73.30 x 200 |
|---|
| 1y Target Est: | 75.34 |
|---|
| Beta: | 0.42 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 71.89 - 73.31 |
|---|
| 52wk Range: | 53.88 - 75.73 |
|---|
| Volume: | 1,003,846 |
|---|
| Avg Vol (3m): | 1,482,050 |
|---|
| Market Cap: | 176.67B |
|---|
| P/E (ttm): | 18.25 |
|---|
| EPS (ttm): | 3.94 |
|---|
| Div & Yield: | 2.53 (3.50%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Novo Nordisk Patent Found InvalidZacks(Wed, Jun 19)
- David Pyott Isn't Just A Pretty Face At Allerganat Investor's Business Daily(Wed, Jun 19)
- This Blockbuster Biologic May Face a Steep Cliffat Motley Fool(Wed, Jun 19)
- Europe Fines Drug Companies for Delaying Genericsat New York Times(Wed, Jun 19)
- Positive Data on Novartis' JakaviZacks(Tue, Jun 18)
- Positive Data on Incyte's JakafiZacks(Tue, Jun 18)
- Ariad's Iclusig in GIST Phase II StudyZacks(Tue, Jun 18)
- Big Pharma's Intellectual Property Bluesat Motley Fool(Tue, Jun 18)
- Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidateat Seeking Alpha(Mon, Jun 17)
- Good News for InterMuneZacks(Mon, Jun 17)
- How big companies can beat the patent chaos of Indiaat Fortune(Mon, Jun 17)
- J&J: Adding Another Pearl to its Acquisition Necklaceat Wall St. Cheat Sheet(Mon, Jun 17)
- [video] Supreme Court Rules on 'Pay for Delay'at CNBC(Mon, Jun 17)
- A Big Pharma Company With a Juicy Dividend Yield and Low Valuationat Motley Fool(Sun, Jun 16)
- 3 Humongous Health-Care Stocks This Weekat Motley Fool(Sat, Jun 15)
Key Statistics
| Forward P/E (1 yr): | 13.29 |
|---|
| P/S (ttm): | 3.11 |
|---|
| Ex-Dividend Date: | 26-Feb-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.10 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.29 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 2.62 |
|---|
Business Summary
Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary...
View More